This website is intended for healthcare professionals only

Trending Topic

Abstract stethoscope integrated with a smartphone screen, representing digital health, telemedicine, and medical technology health care
16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide.1 High systolic blood pressure (SBP) remains one of the top risk factors for CVD burden globally.2 Despite being a modifiable risk factor, hypertension (HTN) remains largely undiagnosed and untreated due to inadequate screening, poor awareness and lack of treatment adherence.3 Globally, HTN is undiagnosed in about 46% […]

177/Efficacy of biventricular stimulation after radiofrequency ablation of AV node in patients with persistent atrial fibrillation

BA Akhyt (Presenting Author) – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; RR Rekvava – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; KM Koshumbayeva – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; KN Madaliev – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; RT Kuanyshbekova – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr177
Select a Section…
1

Article

Objective: To evaluate the effectiveness of biventricular stimulation after the destruction of AV-node in patients with persistent atrial fibrillation (AF) and chronic heart failure (CHF).

Materials and methods: The observational single-centre study included 34 patients with mean age 61,8 ± 9.4 years. All the patients were diagnosed with CHF functional classes III, IV according to New York Heart Association (NYHA) and had poorly controlled persistent AF. At the enrolment point, patients received beta-blockers, ACE inhibitors, diuretics (including aldosterone antagonists), antiplatelet agents, anticoagulants, and statins (if indicated). Radiofrequency ablation of the AV node with implantation of a resynchronisation device (biventricular stimulation) were performed in all patients. Before and 12 months after the intervention we utilized an echocardiography to evaluate cardiac structure and its functions.

Results: The follow-up showed that 12 months after the intervention, there was an increase in the left ventricular ejection fraction (EF) from 32.95 ± 6.84% to 42.89 ± 8.91% (p<0.0001). We observed a decrease in the end-systolic volume (ESV) from 113.32 ± 48.54 ml to 93.83 38.3 ml (p<0.0001). There were no changes on the left ventricular stroke volume (73.41 ± 15.56 ml at the baseline compared with 74.26 ± 20.56 ml 12 months later, p<0.737). The six-minute walk test (SMWT) results increased from 241.3 ± 56.2 m to 362.1 ± 72.2 (p<0.0001).

Conclusions: Biventricular stimulation after radiofrequency ablation of AV node in patients with poorly controlled persistent atrial fibrillation, advanced CHF resulted with an EF, and SMWT improvement, as well as ESV decrease within 12 months observation period.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup